End Points, Collection, Processing, and Time: Four Key Elements to Consider When Planning for Use of Handheld Devices in a Drug Development Setting
暂无分享,去创建一个
Anne C Heatherington | Vivek Pradhan | Indranil Bhattacharya | I. Bhattacharya | A. Heatherington | V. Pradhan
[1] J. N. van den Anker,et al. Primary Endpoints in Pediatric Efficacy Trials Submitted to the US FDA , 2018, Journal of clinical pharmacology.
[2] T Fredriksson,et al. Severe psoriasis--oral therapy with a new retinoid. , 1978, Dermatologica.
[3] Paul O’Donohoe,et al. Capturing Patient-Reported Outcome (PRO) Data Electronically: The Past, Present, and Promise of ePRO Measurement in Clinical Trials , 2014, The Patient - Patient-Centered Outcomes Research.
[4] Shiew-Mei Huang,et al. Real‐World Data and Clinical Pharmacology: A Regulatory Science Perspective , 2019, Clinical pharmacology and therapeutics.
[5] Francesco Muntoni,et al. The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[6] Jennifer C. Goldsack,et al. Use of Mobile Devices to Measure Outcomes in Clinical Research, 2010–2016: A Systematic Literature Review , 2018, Digital Biomarkers.